Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$49.47 - $53.77 $7,173 - $7,796
-145 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$42.91 - $52.5 $1,759 - $2,152
41 Added 39.42%
145 $7,000
Q1 2020

May 15, 2020

BUY
$38.02 - $51.66 $950 - $1,291
25 Added 31.65%
104 $5,000
Q2 2019

Aug 14, 2019

SELL
$40.43 - $44.3 $3,598 - $3,942
-89 Reduced 52.98%
79 $3,000
Q1 2019

May 15, 2019

SELL
$40.83 - $45.43 $1,306 - $1,453
-32 Reduced 16.0%
168 $7,000
Q3 2018

Nov 14, 2018

BUY
$40.0 - $44.84 $3,480 - $3,901
87 Added 76.99%
200 $9,000
Q1 2018

May 15, 2018

BUY
$38.98 - $45.76 $1,948 - $2,288
50 Added 79.37%
113 $5,000
Q4 2017

Feb 14, 2018

BUY
$42.86 - $50.61 $2,700 - $3,188
63
63 $3,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $121B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Martin Currie LTD Portfolio

Follow Martin Currie LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martin Currie LTD, based on Form 13F filings with the SEC.

News

Stay updated on Martin Currie LTD with notifications on news.